Agreed. I’ve had the same experience. He comes across as extremely arrogant and rarely provides any meaningful insights when asked about stocks in his plans. If you question him repeatedly, he simply blocks you. He also seems to have very limited understanding of companies outside his own investments and acts as though everyone else knows nothing.
The performance of his plans has also been quite disappointing. While he did manage to generate some good returns in the past, I feel a lot of that was down to luck and timing, particularly during COVID, when markets had fallen significantly and the subsequent recovery created plenty of opportunities.
🚨 CAS doing its magic again! 🪄📊
Yesterday’s Closing Auction Session gave us some fascinating “price discovery” 🤔 — and today the market seems busy discovering where those prices actually belong! 😂
🏦 BANK NIFTY
🔺 CAS Close: 58,025
🔻 Today’s Low: 57,317
💨 ~700 points vanished!
📉 Axis Bank
🔺 CAS Close: ₹1,300
🔻 Today: ~₹1,258
💸 ~3.2% lower
Maybe SEBI Chairman Tuhin Kanta Pandey can help us understand this new definition of “efficient price discovery”. 😅🙏
When Spot, Futures & the next day’s market are telling three different stories… CAS is certainly making the closing bell entertaining! 🍿🎢
Price Discovery 🔍 or Price Distortion 🤡?
#SEBI #NSE #CAS #BankNifty #StockMarket #Trading
Amazon Pay Gift Cards are BACK on HDFC SmartBuy! 🔥💳
And this time, there are different reward options depending on how you buy 👀
🎁 Amazon Pay Gift Card
💰 Insta Deals: 1% Instant Discount + 1X RPs
⚡ Other SmartBuy reward options may offer accelerated Reward Points depending on your card/route
Great to see Amazon Pay vouchers available on SmartBuy again! 🙌
#HDFC #SmartBuy #AmazonPay #CreditCards #RewardPoints
🚨 CAS is creating some serious price distortions at the close!
Look at BANK NIFTY today:
🔹 Spot before CAS: 57,397
🔹 Spot after CAS: 58,025
🔹 Futures: ~57,886
That leaves Spot trading around 139 points ABOVE Futures at the close! 😳
And look at some of the moves CAS produced in individual stocks:
📈 Laurus Labs: ₹1,862 → ₹1,915 (+₹53)
📈 Axis Bank: ₹1,264 → ₹1,300 (+₹36)
📈 Indian Bank: ₹872 → ₹898 (+₹26)
📈 Federal Bank: ₹346 → ₹357 (+₹11)
📉 Astral: ₹1,570 → ₹1,522 (-₹48)
📉 SBI Card: ₹666 → ₹644 (-₹22)
Cash is discovering its closing price through CAS while F&O trades until 3:40 PM with its existing closing-price methodology.
This is creating some very interesting — and at times bizarre — closing price dislocations.
CAS definitely needs a closer look. 👀
#NSE #CAS #BankNifty #Futures #StockMarket #Trading
🚀 MCX is on a roll!
Barely weeks after its blockbuster quarter, MCX has smashed another record — ₹62.93 lakh crore in daily turnover on 28 August! 🔥📈
And the momentum looks structural, not seasonal:
⚡ Options activity is accelerating
🏆 Participation and liquidity are steadily rising
🥇 Bullion & energy contracts continue to see strong traction
💰 The asset-light exchange model means higher volumes can drive powerful operating leverage
This is exactly why exchange businesses are such compelling long-term stories: as India’s commodity markets deepen, MCX stands to benefit. 🎯
#MCX #IndianStocks #StockMarket #Investing #CommodityMarkets
🚀 MCX just delivered another blockbuster quarter! 💥📈
💰 Revenue: ₹702 Cr (+88% YoY) 📊
💵 PAT: ₹413 Cr (+103% YoY) 🚀
🔥 EBITDA: ₹494 Cr (+105% YoY)
💎 EBITDA Margin: 70.3% (vs 64.7% YoY)
What’s powering the growth? 👇
✅ Robust commodity trading volumes across bullion & energy ⚡🥇🛢️
✅ Operating leverage continues to drive earnings 📈
✅ Exceptional margins showcasing the strength of the exchange model 💪
✅ Structural tailwinds from rising participation in India’s commodity markets 🇮🇳📈
✅ Strong cash generation and a scalable, asset-light business 💰
Just a few days ago, I highlighted why I remain bullish on exchange businesses. MCX has now backed that thesis with stellar execution. 🎯
As India’s financial markets deepen, MCX is uniquely positioned to benefit from the long-term growth in commodity derivatives. 🚀🌟
#MCX #IndianStocks #StockMarket #Earnings #Investing 📈
🚀 Tempsens delivered a blockbuster listing! 🔥
Listed at a remarkable 110.4% premium—the best IPO debut of the year among issues above ₹500 crore. 📈🏆
Added it to the portfolio on listing day. 💼 The debut is impressive; now, let’s see how the business execution and growth story unfold from here. 👀
#Tempsens #IPO #IndianStocks #Investing
After nearly two years, the stock is retesting its 2024 peak near ₹2,000—closing at ₹2,006.8, up 5.5% today. 🔥
A decisive breakout and sustained move above this level could mark the start of the next leg up. 👀
#Coforge#IndianStocks#StockMarket
Coforge follow-up 🚀
Added aggressively around the ₹1,000 level—and the conviction remains intact. 📈
Record deal wins. Expanding margins. AI-led execution. A strong large-deal pipeline.
When growth and profitability improve together, the market eventually takes notice. 👀
#Coforge #IndianIT #IndianStocks #Investing
🚀 Ather Energy: ₹1,000 to ₹1,530+ — up over 50%.
Added in significant quantity around the ₹600 level and continue to hold. 📈
The market is now pricing in the improving fundamentals: strong growth, positive EBITDA trajectory and a credible path to scale.
Disclosure: Invested. Not a recommendation.
🚀 Just a month ago, I said Ather Energy’s story was shifting from survival to scale.
The market is finally catching on. 📈
✅ Q1 FY27 revenue almost doubled YoY
✅ EBITDA turned positive for the first time
✅ Net loss shrank sharply to just ₹51 Cr
✅ Stock surged ~18% post results
The roadmap is getting stronger:
⚡ Affordable EL platform
🏭 Factory 3.0 capacity expansion
🛵 Premium + mass market strategy
💻 Higher software & services contribution
This is no longer just an EV growth story—it’s becoming an operating leverage story. 👀 #AtherEnergy #IndianStocks #Investing
Coforge follow-up 🚀
Added aggressively around the ₹1,000 level—and the conviction remains intact. 📈
Record deal wins. Expanding margins. AI-led execution. A strong large-deal pipeline.
When growth and profitability improve together, the market eventually takes notice. 👀
#Coforge #IndianIT #IndianStocks #Investing
🔥 Coforge is making a strong case for being India’s fastest-growing Tier-1 IT company.
While much of the IT sector is still talking about an AI recovery, Coforge is already delivering it. 🚀
Q1 FY27 Highlights 📊
💥 Revenue: ₹5,528 Cr (+49% YoY)
💥 PAT: ₹519 Cr (+110% YoY)
💥 EBITDA Margin: 20.3% (+285 bps YoY)
What stood out from the management commentary? 👇
✅ Record 12-month signed order book of $2.23 Bn (+44% YoY) — the highest ever.
✅ 86% of revenue comes from AI-led Engineering, Data & Cloud services.
✅ Encora integration is complete, unlocking cross-selling opportunities and scale benefits.
✅ AI-led productivity is driving margin expansion.
✅ Management expects FY27 to be another exceptional year, backed by a strong large-deal pipeline and robust demand visibility.
💡 This isn’t just growth—it’s market share gains.
Record deal wins. Expanding margins. AI-native capabilities. Consistent execution.
When an IT company grows this fast while improving profitability, the market pays attention. 👀
#Coforge #AI #IndianIT #IndianStocks #StockMarket #Investing
🚀 16 years of Zerodha — the numbers tell an incredible story.
Nithin Kamath’s latest update has some fascinating insights into how Zerodha is evolving 👇
🏆 Largest broker by total client AUM
📈 ₹9,000+ Cr MTF book, with clients borrowing ~₹6,000 Cr
💰 MTF now contributes ~10% of revenues, helping offset the decline in transaction-fee income
🏦 Zerodha estimates it needs ~₹11,000 Cr of capital to support the business at its current scale
👥 And remarkably, <100 people run tech, product, business & operations
But the next chapter could be even more interesting 👀
🇺🇸 US stocks on Kite — coming soon
📊 Mutual fund transactions on Kite — coming soon
🌍 NRI investing — identified as a major growth opportunity
🌱 Rainmatter — continuing to diversify beyond broking
The bigger takeaway?
Zerodha knows traditional broking revenues face regulatory & competitive pressure, so it is quietly building new revenue streams + products + ecosystem bets around its massive customer base.
Bootstrapped. Highly capital efficient. Still thinking long term after 16 years. 🔥
Indian capital markets are getting bigger — and Zerodha clearly wants to become much more than just a broker.
#Zerodha #NithinKamath #StockMarket #Fintech #IndianMarkets
India’s E20 policy deserves a closer look.
On paper, the achievements are significant:
⛽ ~20% ethanol blending
💰 ₹1.44 lakh crore+ forex saved
🛢️ ~245 lakh tonnes of crude substituted
🌾 ₹1.25 lakh crore+ paid to farmers
But here’s what surprised me 👇
The Government itself now says:
→ Average ethanol procurement cost: ₹71.32/litre
→ Maize ethanol: ₹71.86/litre before some downstream costs
→ At ~$70 crude, E20 is actually costlier to produce than pure petrol
And then there is the consumer.
NITI Aayog estimated E20 could reduce fuel efficiency by as much as 6–7% in certain older four-wheelers.
Its own roadmap even discussed compensating consumers for the mileage loss, while the auto industry recommended keeping E10 available as a protection-grade fuel for existing vehicles.
Meanwhile, the Economic Survey shows another unintended consequence:
🌽 Maize acreage CAGR FY22–25: +6.68%
🌽 Maize production CAGR: +8.77%
while pulse acreage and production declined.
So the question isn’t whether ethanol has benefits. Clearly it does.
The real question is:
If ethanol is now more expensive than petrol, some vehicles can deliver lower mileage, and agricultural incentives are shifting towards fuel crops — what exactly is the benefit reaching the ordinary petrol consumer?
Energy security matters.
But good policy should also make economic sense for the person paying at the pump.
🚀 Urban Company: Core business is firing 🔥… while InstaHelp is burning cash to build scale! ⚡
Q1 FY27 was a fascinating quarter 👇
📈 Revenue: ₹528 Cr | +44% YoY
💰 NTV: ₹1,465 Cr | +42% YoY
📦 Orders: 13.2 Mn | +79% YoY
👥 Added ~1.2 Mn new customers — highest ever!
But PAT? ₹92 Cr LOSS 🔴
The reason 👉 InstaHelp investment.
Strip that out and the picture looks very different 👀
💎 CORE INDIA BUSINESS
🔥 NTV crossed ₹1,000 Cr/quarter for the first time
📈 Growth accelerated to 29% YoY
💰 Adj. EBITDA margin: 6.9%, +170 bps
🎯 Long-term potential: 9–10% NTV margin
🌍 INTERNATIONAL — emerging profit engine
🚀 NTV +76% YoY
✅ UAE & Singapore profitable
🇸🇦 Saudi Arabia scaling up
🏠 NATIVE — moving in the right direction
📈 NTV +51% YoY
🚀 Revenue +60% YoY
📊 EBITDA margin improved ~410 bps
⚡ INSTAHELP = THE BIG BET 🎲
📦 3.82 Mn orders in Q1
🚀 +43% QoQ
But…
🔴 EBITDA loss: ~₹132 Cr
The key metric to watch 👇
📉 Loss/order improved from
₹447 ➡️ ₹346 QoQ ✅
And here’s the number that caught my attention 👀👇
💰 Ex-InstaHelp, Urban Company generated ~₹67 Cr Adj. EBITDA — +116% YoY! 🔥🔥
🎯 MANAGEMENT TARGETS
⏳ Consolidated Adj. EBITDA breakeven → Q3 FY28
💰 Adj. EBITDA target → ₹1,000 Cr by FY31
🏦 Cash + treasury investments → ~₹2,019 Cr
So the UC story increasingly looks like 👇
🔥 Core UC → Growth + Margin Expansion
🌍 International → Emerging Profit Engine
🏠 Native → Heading towards profitability
⚡ InstaHelp → High-risk, potentially high-reward bet
For me, EVERYTHING comes down to one question 👇
🧐 Can InstaHelp keep exploding in scale while loss/order falls sharply?
If YES…
🚀 Urban Company could eventually have multiple growth engines firing together.
Definitely one to track closely 👀📊
#UrbanCompany #URBANCO #IndianStocks #Investing #StockMarket
🚨 WELSPUN CORP — This is BIG! 🇺🇸🔥
Welspun just won the LARGEST single order in its history:
💰 ₹17,200 Cr / $1.8 BILLION
🇺🇸 Supply from its US facility
📅 Execution across FY28–FY29
👉 Global order book now at a RECORD ₹42,100 Cr ($4.4bn)! 🤯
But the order is only part of the story 👇
Q1 FY27 was already firing:
🔥 Highest-ever quarterly EBITDA: ₹756 Cr (+35% YoY)
💰 Net Cash: ₹2,336 Cr
📈 ROCE: 23.1%
🏗️ And this was AFTER ~₹834 Cr capex
The last concall had some VERY interesting clues:
🇺🇸 US EBITDA/ton: Management's sustainable benchmark is ~$300/ton — but said current profitability is even higher.
⚡ AI/Data Center opportunity: ~25% of the then US order mix was linked to pipelines feeding growing data-center power demand, with management expecting this share to INCREASE.
⛽ LNG remains huge — ~75% of the mix was linked to Gulf Coast/LNG exports.
🚀 Management sees structural US demand for the next 5–7 YEARS, driven by LNG + AI/data-centre power demand + oil & gas infrastructure.
🏭 US HFIW capacity already commissioned; new LSAW capacity targeted within FY27.
🇸🇦 Saudi expansion also progressing — adding another growth engine.
And here's the most interesting part…
During the July concall, management said existing orders were largely booked through FY28, while discussions for FY29 were gaining traction.
Just weeks later → a $1.8 BILLION order arrives, with execution extending into FY29. 👀
Record order book.
Strong balance sheet.
20%+ ROCE.
US + Saudi expansion.
AI/Data Centres + LNG tailwinds.
Multi-year visibility.
Welspun Corp is turning into a serious global energy-infrastructure play. 🌎🔥
Execution + valuation are the key things to track from here.
#WelspunCorp #WELCORP #IndianStocks #Investing
🚨 Big overnight cues for Indian IT!
Wall Street is flashing strong signals for Indian IT tonight:
🔥 Accenture +6.6%
🔥 Salesforce +5.6%
🔥 Infosys ADR +3%
That’s a powerful tailwind heading into tomorrow’s India open.
👀 Infosys, TCS, HCL Tech, Wipro & Tech Mahindra could be the stocks to watch.
Moderna and @Merck today announced positive topline results from the Phase 3 INTerpath-001 trial evaluating adjuvant treatment with intismeran autogene, a novel investigational mRNA-based individualized neoantigen therapy jointly developed by Merck and Moderna, in combination with KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in patients with completely resected Stage IIB-IV melanoma.
Read more:
🚨 A major milestone for cancer treatment and mRNA technology.
Moderna & Merck’s personalized mRNA cancer vaccine, intismeran autogene, combined with Keytruda has succeeded in a Phase 3 trial involving 1,137 patients with high-risk melanoma—significantly improving recurrence-free and distant metastasis-free survival versus Keytruda alone.
Earlier 5-year Phase 2b data showed:
🔹 49% lower risk of cancer recurrence or death
🔹 59% lower risk of distant metastasis or death
The exact Phase 3 efficacy percentages haven’t been released yet.
This is the first positive Phase 3 trial of an individualized mRNA-based cancer therapy—a potentially historic validation of using mRNA to train the immune system to target mutations unique to each patient’s tumor.
From COVID vaccines to personalized cancer treatment, mRNA technology may be entering its most exciting chapter yet.
#Moderna #Merck #mRNA #CancerVaccine #Melanoma #Biotech
The latest data actually strengthens the point.
Yes, Netflix revenue growth has slowed: 16% in 2025 → 13% in Q2’26. But slower growth ≠ people getting “bored” of OTT.
Viewing hours GREW 2% in H1’26. Netflix crossed 325m subscribers. Ad revenue is on track to roughly double to ~$3bn. Operating margin is 33%+.
At Netflix’s scale, subscriber growth inevitably slows. The question is whether it can grow engagement, monetisation and profits from that massive base. So far, it is.
There’s a legitimate debate on valuation and slowing growth. But “OTT boredom” simply isn’t what the latest numbers show.
Recent price movement has more to do with acquisition speculation than people getting “bored” of OTT.
Netflix went from 260m to 302m paid subscribers in 2024 — up 16%, with a record 19m additions in Q4 alone. Hardly signs of consumer fatigue.
And good content is subjective — India alone continues to have strong releases. Cinema can recover while OTT grows.
Given your position in the stock, this feels more like the same narrative you’ve been pushing for years than what the data suggests.
🚨 India’s tax story has flipped. 🇮🇳💸
FY15 → FY24:
👤 Personal Income Tax*: ₹2.66L Cr → ₹10.45L Cr (+293%)
🏢 Corporate Tax: ₹4.29L Cr → ₹9.11L Cr (+112%)
🤯 Individuals now collectively pay MORE direct tax than companies.
🌍 Common in richer economies.
⚡ Striking for India because of how quickly the shift happened.
The big question:
👉 Have household incomes & public services improved just as fast?
*PIT series includes STT.